Cargando…

Molecular and Cytogenetic Analysis of Romanian Patients with Differences in Sex Development

Differences in sex development (DSD) are often correlated with a genetic etiology. This study aimed to assess the etiology of DSD patients following a protocol of genetic testing. Materials and methods. This study prospectively investigated a total of 267 patients with DSD who presented to Clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Miclea, Diana, Alkhzouz, Camelia, Bucerzan, Simona, Grigorescu-Sido, Paula, Popp, Radu Anghel, Pascanu, Ionela Maria, Cret, Victoria, Ghervan, Cristina, Blaga, Ligia, Zaharie, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620580/
https://www.ncbi.nlm.nih.gov/pubmed/34829455
http://dx.doi.org/10.3390/diagnostics11112107
_version_ 1784605253828608000
author Miclea, Diana
Alkhzouz, Camelia
Bucerzan, Simona
Grigorescu-Sido, Paula
Popp, Radu Anghel
Pascanu, Ionela Maria
Cret, Victoria
Ghervan, Cristina
Blaga, Ligia
Zaharie, Gabriela
author_facet Miclea, Diana
Alkhzouz, Camelia
Bucerzan, Simona
Grigorescu-Sido, Paula
Popp, Radu Anghel
Pascanu, Ionela Maria
Cret, Victoria
Ghervan, Cristina
Blaga, Ligia
Zaharie, Gabriela
author_sort Miclea, Diana
collection PubMed
description Differences in sex development (DSD) are often correlated with a genetic etiology. This study aimed to assess the etiology of DSD patients following a protocol of genetic testing. Materials and methods. This study prospectively investigated a total of 267 patients with DSD who presented to Clinical Emergency Hospital for Children Cluj-Napoca between January 2012 and December 2019. Each patient was clinically, biochemically, and morphologically evaluated. As a first intervention, the genetic test included karyotype + SRY testing. A high value of 17-hydroxyprogesterone was found in 39 patients, in whom strip assay analysis of the CYP21A2 gene was subsequently performed. A total of 35 patients were evaluated by chromosomal microarray technique, and 22 patients were evaluated by the NGS of a gene panel. Results. The karyotype analysis established the diagnosis in 15% of the patients, most of whom presented with sex chromosome abnormalities. Genetic testing of CYP21A2 established a confirmation of the diagnosis in 44% of patients tested. SNP array analysis was particularly useful in patients with syndromic DSD; 20% of patients tested presented with pathogenic CNVs or uniparental disomy. Gene panel sequencing established the diagnosis in 11 of the 22 tested patients (50%), and the androgen receptor gene was most often involved in these patients. The genes that presented as pathogenic or likely pathogenic variants or variants of uncertain significance were RSPO1, FGFR1, WT1, CHD7, AR, NIPBL, AMHR2, AR, EMX2, CYP17A1, NR0B1, GNRHR, GATA4, and ATM genes. Conclusion. An evaluation following a genetic testing protocol that included karyotype and SRY gene testing, CYP21A2 analysis, chromosomal analysis by microarray, and high-throughput sequencing were useful in establishing the diagnosis, with a spectrum of diagnostic yield depending on the technique (between 15 and 50%). Additionally, new genetic variants not previously described in DSD were observed.
format Online
Article
Text
id pubmed-8620580
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86205802021-11-27 Molecular and Cytogenetic Analysis of Romanian Patients with Differences in Sex Development Miclea, Diana Alkhzouz, Camelia Bucerzan, Simona Grigorescu-Sido, Paula Popp, Radu Anghel Pascanu, Ionela Maria Cret, Victoria Ghervan, Cristina Blaga, Ligia Zaharie, Gabriela Diagnostics (Basel) Article Differences in sex development (DSD) are often correlated with a genetic etiology. This study aimed to assess the etiology of DSD patients following a protocol of genetic testing. Materials and methods. This study prospectively investigated a total of 267 patients with DSD who presented to Clinical Emergency Hospital for Children Cluj-Napoca between January 2012 and December 2019. Each patient was clinically, biochemically, and morphologically evaluated. As a first intervention, the genetic test included karyotype + SRY testing. A high value of 17-hydroxyprogesterone was found in 39 patients, in whom strip assay analysis of the CYP21A2 gene was subsequently performed. A total of 35 patients were evaluated by chromosomal microarray technique, and 22 patients were evaluated by the NGS of a gene panel. Results. The karyotype analysis established the diagnosis in 15% of the patients, most of whom presented with sex chromosome abnormalities. Genetic testing of CYP21A2 established a confirmation of the diagnosis in 44% of patients tested. SNP array analysis was particularly useful in patients with syndromic DSD; 20% of patients tested presented with pathogenic CNVs or uniparental disomy. Gene panel sequencing established the diagnosis in 11 of the 22 tested patients (50%), and the androgen receptor gene was most often involved in these patients. The genes that presented as pathogenic or likely pathogenic variants or variants of uncertain significance were RSPO1, FGFR1, WT1, CHD7, AR, NIPBL, AMHR2, AR, EMX2, CYP17A1, NR0B1, GNRHR, GATA4, and ATM genes. Conclusion. An evaluation following a genetic testing protocol that included karyotype and SRY gene testing, CYP21A2 analysis, chromosomal analysis by microarray, and high-throughput sequencing were useful in establishing the diagnosis, with a spectrum of diagnostic yield depending on the technique (between 15 and 50%). Additionally, new genetic variants not previously described in DSD were observed. MDPI 2021-11-14 /pmc/articles/PMC8620580/ /pubmed/34829455 http://dx.doi.org/10.3390/diagnostics11112107 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Miclea, Diana
Alkhzouz, Camelia
Bucerzan, Simona
Grigorescu-Sido, Paula
Popp, Radu Anghel
Pascanu, Ionela Maria
Cret, Victoria
Ghervan, Cristina
Blaga, Ligia
Zaharie, Gabriela
Molecular and Cytogenetic Analysis of Romanian Patients with Differences in Sex Development
title Molecular and Cytogenetic Analysis of Romanian Patients with Differences in Sex Development
title_full Molecular and Cytogenetic Analysis of Romanian Patients with Differences in Sex Development
title_fullStr Molecular and Cytogenetic Analysis of Romanian Patients with Differences in Sex Development
title_full_unstemmed Molecular and Cytogenetic Analysis of Romanian Patients with Differences in Sex Development
title_short Molecular and Cytogenetic Analysis of Romanian Patients with Differences in Sex Development
title_sort molecular and cytogenetic analysis of romanian patients with differences in sex development
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620580/
https://www.ncbi.nlm.nih.gov/pubmed/34829455
http://dx.doi.org/10.3390/diagnostics11112107
work_keys_str_mv AT micleadiana molecularandcytogeneticanalysisofromanianpatientswithdifferencesinsexdevelopment
AT alkhzouzcamelia molecularandcytogeneticanalysisofromanianpatientswithdifferencesinsexdevelopment
AT bucerzansimona molecularandcytogeneticanalysisofromanianpatientswithdifferencesinsexdevelopment
AT grigorescusidopaula molecularandcytogeneticanalysisofromanianpatientswithdifferencesinsexdevelopment
AT poppraduanghel molecularandcytogeneticanalysisofromanianpatientswithdifferencesinsexdevelopment
AT pascanuionelamaria molecularandcytogeneticanalysisofromanianpatientswithdifferencesinsexdevelopment
AT cretvictoria molecularandcytogeneticanalysisofromanianpatientswithdifferencesinsexdevelopment
AT ghervancristina molecularandcytogeneticanalysisofromanianpatientswithdifferencesinsexdevelopment
AT blagaligia molecularandcytogeneticanalysisofromanianpatientswithdifferencesinsexdevelopment
AT zahariegabriela molecularandcytogeneticanalysisofromanianpatientswithdifferencesinsexdevelopment